Palmitoyl protein thioesterase 1 (PPT1) deficiency causes endocytic defects connected to abnormal saposin processing

被引:31
作者
Ahtiainen, Laura
Luiro, Kaisu
Kauppi, Maria
Tyynela, Jaana
Kopra, Outi
Jalanko, Anu
机构
[1] Natl Publ Hlth Inst, Dept Mol Med, Biomedicum, Helsinki, Finland
[2] Univ Helsinki, Inst Biomed Biochem, FIN-00014 Helsinki, Finland
基金
芬兰科学院;
关键词
palmitoyl protein thioesterase 1; saposin processing; endocytic pathway;
D O I
10.1016/j.yexcr.2006.01.034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Infantile neuronal ceroid lipofuscinosis (INCL) is a severe neurodegenerative disorder of the childhood caused by mutations in the gene encoding palmitoyl protein thioesterase I (PPT1), PPT1 localizes to late endosomes/lysosomes of non-neuronal cells and in neurons also to presynaptic areas. PPTI-deficiency causes massive death of cortical neurons and most tissues show an accumulation of saposins A and D. We have here studied endocytic pathways, saposin localization and processing in PPT1-deficient fibroblasts to elucidate the cellular defects resulting in accumulation of specific saposins. we show that PPT1-deficiency causes a defect in fluid-phase and receptor-mediated endocytosis, whereas marker uptake and recycling endocytosis remain intact. Furthermore, we show that saposins A and D are more abundant and relocalized in PPT-deficient fibroblasts and mouse primary neurons. Metabolic labeling and immunoprecipitation analyses revealed hypersecretion and abnormal processing of prosaposin, implying that the accumulation of saposins may result from endocytic defects. We show for the first time a connection between saposin storage and a defect in the endocytic pathway of INCL cells. These data provide new insights into the metabolism of PPT1-deficient cells and offer a basis for further studies on cellular processes causing neuronal death in INCL and other neurodegenerative diseases. (c) 2006 Published by Elsevier Inc.
引用
收藏
页码:1540 / 1553
页数:14
相关论文
共 48 条
[1]   Palmitoyl protein thioesterase 1 is targeted to the axons in neurons [J].
Ahtiainen, L ;
Van Diggelen, OP ;
Jalanko, A ;
Kopra, O .
JOURNAL OF COMPARATIVE NEUROLOGY, 2003, 455 (03) :368-377
[2]  
ALVAREZ E, 1990, J BIOL CHEM, V265, P16644
[3]   BAFILOMYCINS - A CLASS OF INHIBITORS OF MEMBRANE ATPASES FROM MICROORGANISMS, ANIMAL-CELLS, AND PLANT-CELLS [J].
BOWMAN, EJ ;
SIEBERS, A ;
ALTENDORF, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (21) :7972-7976
[4]  
CAMP LA, 1993, J BIOL CHEM, V268, P22566
[5]   Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders [J].
Cataldo, A ;
Rebeck, GW ;
Ghetti, B ;
Hulette, C ;
Lippa, C ;
Van Broeckhoven, C ;
van Duijn, C ;
Cras, P ;
Bogdanovic, N ;
Bird, T ;
Peterhoff, C ;
Nixon, R .
ANNALS OF NEUROLOGY, 2001, 50 (05) :661-665
[6]   Endocytic pathway abnormalities precede amyloid β deposition in sporadic Alzheimer's disease and Down syndrome -: Differential effects of APOE genotype and presenilin mutations [J].
Cataldo, AM ;
Peterhoff, CM ;
Troncosco, JC ;
Gomez-Isla, T ;
Hyman, BT ;
Nixon, RA .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (01) :277-286
[7]   The yeast model for Batten disease: a role for Btn2p in the trafficking of the Golgi-associated vesicular targeting protein, Yif1p [J].
Chattopadhyay, S ;
Roberts, PM ;
Pearce, DA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 302 (03) :534-538
[8]   Abnormal transport along the lysosomal pathway in Mucolipidosis, type IV disease [J].
Chen, CS ;
Bach, G ;
Pagano, RE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6373-6378
[9]  
CLAGUE MJ, 1994, J BIOL CHEM, V269, P21
[10]  
FUJIBAYASHI S, 1986, J BIOL CHEM, V261, P5339